The latest immunotherapy news and developments
Bacteria help discover human cancer-causing proteins
A team led by researchers at Baylor College of Medicine and the University of Texas…
Browsing: Immunotherapy
VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has…
Anticancer vaccines gain new lease of life with personalisation techniques
Anticancer vaccines have gained a new lease of life with techniques to personalise them to…
Vaccine, checkpoint drugs combination shows promise for pancreatic cancers
Researchers have discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic…
ASH 2018: A first stem cell transplant after CAR T-Cell therapy reduces relapses in ALL
In a new study presented at ASH 2018 in San Diego, patients with ALL who received a…
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…
ASH 2018: Daratumumab increases progression-free survival in transplant-ineligible multiple myeloma
Interim results from a large international phase III clinical trial show that adding the immunotherapy…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
Major breakthrough in quest for cancer vaccine
The idea of a cancer vaccine is something researchers have been working on for over…
ASH 2018: New research on stem cell transplantation for myeloid cancers
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation was the focus…